239 related articles for article (PubMed ID: 31355848)
1. Pseudomonas aeruginosa populations in the cystic fibrosis lung lose susceptibility to newly applied β-lactams within 3 days.
Tueffers L; Barbosa C; Bobis I; Schubert S; Höppner M; Rühlemann M; Franke A; Rosenstiel P; Friedrichs A; Krenz-Weinreich A; Fickenscher H; Bewig B; Schreiber S; Schulenburg H
J Antimicrob Chemother; 2019 Oct; 74(10):2916-2925. PubMed ID: 31355848
[TBL] [Abstract][Full Text] [Related]
2. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
[TBL] [Abstract][Full Text] [Related]
3. Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with β-lactams.
Clark ST; Sinha U; Zhang Y; Wang PW; Donaldson SL; Coburn B; Waters VJ; Yau YCW; Tullis DE; Guttman DS; Hwang DM
Int J Antimicrob Agents; 2019 May; 53(5):620-628. PubMed ID: 30664925
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
5. Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung.
Diaz Caballero J; Clark ST; Coburn B; Zhang Y; Wang PW; Donaldson SL; Tullis DE; Yau YC; Waters VJ; Hwang DM; Guttman DS
mBio; 2015 Sep; 6(5):e00981-15. PubMed ID: 26330513
[TBL] [Abstract][Full Text] [Related]
6. Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis.
Kuti JL; Pettit RS; Neu N; Cies JJ; Lapin C; Muhlebach MS; Novak KJ; Nguyen ST; Saiman L; Nicolau DP
Diagn Microbiol Infect Dis; 2015 Sep; 83(1):53-5. PubMed ID: 26003469
[TBL] [Abstract][Full Text] [Related]
7. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
[TBL] [Abstract][Full Text] [Related]
8. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.
Wolter DJ; Acquazzino D; Goering RV; Sammut P; Khalaf N; Hanson ND
Clin Infect Dis; 2008 Jun; 46(12):e137-41. PubMed ID: 18462098
[TBL] [Abstract][Full Text] [Related]
9. The effects of inhaled aztreonam on the cystic fibrosis lung microbiome.
Heirali AA; Workentine ML; Acosta N; Poonja A; Storey DG; Somayaji R; Rabin HR; Whelan FJ; Surette MG; Parkins MD
Microbiome; 2017 May; 5(1):51. PubMed ID: 28476135
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance evolution of Pseudomonas aeruginosa in cystic fibrosis patients (2010-2013).
Lucca F; Guarnieri M; Ros M; Muffato G; Rigoli R; Da Dalt L
Clin Respir J; 2018 Jul; 12(7):2189-2196. PubMed ID: 29498795
[TBL] [Abstract][Full Text] [Related]
11. The role of hypermutation and collateral sensitivity in antimicrobial resistance diversity of
Vanderwoude J; Azimi S; Read TD; Diggle SP
mBio; 2024 Feb; 15(2):e0310923. PubMed ID: 38171021
[No Abstract] [Full Text] [Related]
12. Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study.
Courtois N; Caspar Y; Maurin M
Int J Antimicrob Agents; 2018 Sep; 52(3):358-364. PubMed ID: 29775685
[TBL] [Abstract][Full Text] [Related]
13. Genomic and Functional Characterization of Longitudinal Pseudomonas aeruginosa Isolates from Young Patients with Cystic Fibrosis.
Chandler CE; Hofstaedter CE; Hazen TH; Rasko DA; Ernst RK
Microbiol Spectr; 2023 Aug; 11(4):e0155623. PubMed ID: 37358436
[TBL] [Abstract][Full Text] [Related]
14. Changes in the lung bacteriome in relation to antipseudomonal therapy in children with cystic fibrosis.
Kramná L; Dřevínek P; Lin J; Kulich M; Cinek O
Folia Microbiol (Praha); 2018 Mar; 63(2):237-248. PubMed ID: 29127619
[TBL] [Abstract][Full Text] [Related]
15. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.
Beringer PM; Bensman TJ; Ho H; Agnello M; Denovel N; Nguyen A; Wong-Beringer A; She R; Tran DQ; Moskowitz SM; Selsted ME
J Antimicrob Chemother; 2016 Jan; 71(1):181-8. PubMed ID: 26433781
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility between two readout methods of a commercial broth microdilution assay for Pseudomonas aeruginosa isolates from patients with Cystic Fibrosis.
Franssens BT; Fluit AC; Rentenaar RJ
Infect Dis (Lond); 2019 Jan; 51(1):50-55. PubMed ID: 30654670
[TBL] [Abstract][Full Text] [Related]
17. Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa.
Pages-Monteiro L; Marti R; Commun C; Alliot N; Bardel C; Meugnier H; Perouse-de-Montclos M; Reix P; Durieu I; Durupt S; Vandenesch F; Freney J; Cournoyer B; Doleans-Jordheim A
PLoS One; 2017; 12(3):e0173022. PubMed ID: 28282386
[TBL] [Abstract][Full Text] [Related]
18. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
Millar BC; Rendall JC; Downey DG; Moore JE
J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
[TBL] [Abstract][Full Text] [Related]
19. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis unit.
Denton M; Littlewood JM; Brownlee KG; Conway SP; Todd NJ
Lancet; 1996 Dec; 348(9041):1596-7. PubMed ID: 8950918
[No Abstract] [Full Text] [Related]
20. Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).
Oermann CM; McCoy KS; Retsch-Bogart GZ; Gibson RL; McKevitt M; Montgomery AB
J Antimicrob Chemother; 2011 Oct; 66(10):2398-404. PubMed ID: 21784781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
